Mesothelioma Resources

Mesothelioma, malignant mesothelioma, more precisely, it is a rare form of cancer that develops from the protective lining that covers many of the internal organs of the body, the mesothelium. It is usually caused by exposure to asbestos.

Their most common location is the pleura (outer lining of the lungs and internal chest wall), but can also occur in the peritoneum (lining of the abdominal cavity), the heart, the pericardium (a sac that surrounds the heart) or tunica vaginalis.

Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to asbestos dust and fibers in other ways. It has also been suggested that washing the clothes of a family member who worked with asbestos can put a person at risk of developing mesothelioma. Unlike lung cancer, there is no association between mesothelioma and smoking, but smoking increases the risk of other asbestos-related cancers. Compensation via asbestos funds or stocks is an important issue in mesothelioma (see asbestos and the law).

Symptoms of mesothelioma include shortness of breath due to pleural effusion (fluid between the lung and the chest wall) or chest pain, and general symptoms such as weight loss. The diagnosis can be suspected with chest radiography and computed tomography, and confirmed with a biopsy (tissue sample) and microscopic examination. A thoracoscopy (inserting a tube with a camera into the chest) can be used to take biopsies. It allows the introduction of substances such as talc to obliterate the pleural space (called pleurodesis), which prevents more fluid from accumulating and pressing on the lung. Despite treatment with chemotherapy, radiotherapy or surgery, sometimes the disease carries a poor prognosis. Research about screening tests for early detection of mesothelioma is ongoing.

Staging is the process of discovering how far the cancer has spread. Staging of mesothelioma is based on imaging studies as x-rays, CT scans and MRI. Mesothelioma treatment and life expectancy of patients with the disease depends largely on the stage (extent of spread) of their cancer. Since pleural mesothelioma occurs most frequently and has been studied more, is the only mesothelioma for which there is a classification stage.

The staging system most often used for cancer mesothelioma is the Butchart System. This system is based mainly on the extent of the primary tumor mass and divides mesotheliomas into stages 1-4.

Butchart staging system

• Phase 1: Mesothelioma is present in the right or left pleura and may also involve the lung, pericardium, or diaphragm (muscle separating the chest from the abdomen) on the same side.
• Phase 2: Mesothelioma invades the chest wall or involves the passage of food from the esophagus (which connects the throat to the stomach), heart, or pleura on both sides. The lymph nodes in the chest may also be involved.
• Phase 3: Mesothelioma has penetrated through the diaphragm into the peritoneum (lining of the abdominal cavity). Lymph nodes beyond those in the breast may also be involved.
• Phase 4: There is evidence of distant metastases (spread through the bloodstream to other organs).

Another staging system was recently developed by the American Joint Committee on Cancer (AJCC). This is a TNM system, similar to staging systems used for most other cancers. T represents the tumor (its size and how far it has spread to nearby organs), N stands for spread to lymph nodes and M is the metastasis (spread to distant organs). In TNM staging, information about the tumor, lymph nodes, and metastasis is combined in a process called phase group to assign a stage described by numbers 1-4. Minor differences exist between the AJCC TNM staging system and the Butchart staging system.

TNM staging system

• Phase 1: Mesothelioma involves right or left pleura. He may also have spread to the lung, pericardium, or diaphragm on the same side. Not yet spread to the lymph nodes.
• Phase 2: Mesothelioma has spread from the pleura on one side to the next peribronchial and / or lymph nodes near the lung on the same side. He may also have spread to the lung, pericardium, or diaphragm on the same side.
• Phase 3: Mesothelioma has spread to the chest wall muscles, ribs, heart, esophagus or other organs in the chest on the same side as the primary tumor, with or without spread to subcarinal and / or mediastinal lymph nodes on the same side as the main tumor. subcarinal nodes are located at the point where the trachea branches to the left and right lungs. Mediastinal lymph nodes are located in the space behind the breast bone in front of the heart. Mesotheliomas with the same degree of local spread as in stage 2, which also spread to subcarinal and / or mediastinal lymph nodes on the same side are also included in Stage 3.
• Phase 4: Mesothelioma has spread to lymph nodes in the chest on the side opposite the primary tumor, or directly extends to the pleura or lung on the opposite side, or directly extends into the peritoneum, or directly extends into organs abdominal cavity or neck. Any mesothelioma with evidence of metastasis (spread to other organs through the bloodstream) or spread to organs beyond the chest or abdomen is included in this phase.

Although the recently developed TNM classification is the most detailed and accurate, the original Butchart staging system is still used most often to describe the spread of pleural mesothelioma. Understanding these staging systems for mesothelioma is important both for estimating the prognosis and better understanding, and also to evaluate therapeutic options.

Prognostic Factors
Because pleural mesothelioma has been better studied than peritoneal mesothelioma know more about the risk factors associated with mesothelioma prognosis for pleural mesothelioma. Younger age at diagnosis, performance status (functional status) and no weight loss is associated with a more favorable prognosis of mesothelioma.

Mesotheliomas are generally three different cell types (histological analysis):

1) epithelial mesothelioma cell type – has the most favorable prognosis,

2) fibrosarcomatous cell type – carries the worst prognosis and

3) the mesothelioma Biphasic or mixed cell type – have an intermediate prognosis.

In determining the extent and nature of any type of cancer – which in turn plays a large role in developing an appropriate treatment of cancer – oncologists use a heading or “test” the system. This is just one of the criteria by which malignant tumors are classified, the first of which is determined by the location of the tumor and the third of which is determined by the cellular structure (or lack thereof).

Staging helps the oncologist to determine how far the cancer has advanced and how treatable malignancy the patient really is.

Although there are three different staging systems currently in use, all three are based in four main steps:

• The tumor is confined to one organ or region, and is relatively small.
• The tumor grew in size and spread to another tissue.
• The tumor has spread to adjacent areas.
• The tumor has spread to distant areas of the body, or “metastasis”.
In Phase 1, mesothelioma is localized and confined to one area of the body.

Butchart System
This is the oldest system used by oncologists, and is used only for patients diagnosed with pleural mesothelioma fashion. In Phase 1, under the Butchart System, the tumor is relatively small and confined to one side of the lung cavity and may also be present in the membrane on the same side.

TNM system
TNM mean tumor, lymph nodes and metastases. This is a newer method that is commonly used for staging of malignant pleural mesothelioma, although it is also used for other types too including peritoneal mesothelioma.

Under this system, mesothelioma cancer is located on one side or the other, and may also be present in the diaphragm and the pericardium (lining of the heart). It is, however, is not present in the lymph nodes.

Brigham System
This is the new testing system, which was specially developed for use with the diagnosis of mesothelioma. Under the first phase of the Brigham system, the cancer is operable and the lymph nodes affected.

Prognosis
The main problem for patients with mesothelioma is that, historically, their condition is not detected until it has reached Stage 3 or Stage 4 mesothelioma mesothelioma – when it is too late to offer anything other than palliative care.

A ray of hope lies in the new diagnostic test ™ MESOMARK recently approved for use in the U.S. by the FDA. This test was developed by a Japanese biotech firm and is reportedly capable of detecting early biological markers of mesothelioma when it is most treatable and has the best chance of cure for mesothelioma. When the disease is detected in stage 1, the cancerous tissue can usually be removed with surgery mesothelioma, mesothelioma radiation and chemotherapy treatments are used to monitor in order to get rid of any trace of malignancy.

In determining the extent and nature of any type of cancer, including mesothelioma – which in turn plays an important role in designing an appropriate course of treatment of mesothelioma – oncologists use a heading or “test” the system. This is just one of the criteria by which malignant tumors are classified, the first of which is determined by the location of the tumor and the third of which is determined by the cellular structure (or lack thereof).

Staging helps the oncologist to determine how far the mesothelioma cancer has advanced and how treatable malignancy the patient really is.

Although there are three different staging systems currently in use, all three are based in four main steps:

• The tumor is confined to one organ or region, and is relatively small.
• The tumor grew in size and spread to another tissue.
• The tumor has spread to adjacent areas.
• The tumor has spread to distant areas of the body, or “metastasis”.

Butchart System
The Butchart System is the oldest item used by oncologists and is employed only in cases of pleural mesothelioma. Butchart tumor classification describes the main tumor size. Under this rubric, the tumor has spread from its point of origin to the other side of the body, or a tissue adjacent to the pericardium.

TNM system
TNM mean tumor, lymph nodes and metastases. This is a fairly new item that is also used in the staging of malignant mesothelioma. This system describes not only the size of the tumor, but also the extent of metastasis and whether or not the lymph nodes are involved.

In Phase 2, TNM, the cancer may have spread to adjacent tissues, such as the diaphragm and / or pericardial lining, however, the main criterion is that it has by this point affected lymph nodes.

Brigham System
The Brigham System is the item most recently developed for use with the diagnosis of mesothelioma. Scope of Phase 2 of the private system, the tumor is still operable (resectable), but has spread to lymph nodes.

Prognosis
In most cases, mesothelioma is not detected until it has reached stage 3 or 4 – when a cure or remission mesothelioma and mesothelioma is not likely everything can be done is to try to make the patient more comfortable.

The new MESOMARK ™ diagnostic test may enable pathologists to detect the disease at earlier stages, however. Recently approved for use in the U.S. by the FDA, this test was developed by a Japanese biotech firm and is reportedly capable of detecting early biological markers of malignant mesothelioma. In Phase 1, the tumor usually can be removed through surgery mesothelioma, mesothelioma radiation and chemotherapy are used to monitor in order to get rid of any trace of malignancy.

In determining the extent and nature of any type of cancer, including mesothelioma – mesothelioma oncologists and use a heading or “test” the system. This is just one of the criteria by which malignant tumors are classified, the first of which is determined by the location of the tumor and the third of which is determined by the types of mesothelioma cells.

Staging helps the oncologist to determine how far the cancer has advanced and asbestos treatable malignancy and the patient really is.

Although there are three different staging systems currently in use, all three are based on four primary steps mesothelioma:

• In Phase 1 of mesothelioma, the tumor is confined to one organ or region, and is relatively small.
• In phase two of mesothelioma, tumor grew in size and spread to another tissue.
• In stage 3 mesothelioma, the tumor spread to adjacent areas.
• In Phase 4 of mesothelioma, the tumor has spread to distant areas of the body, or “metastasis”.

Butchart System
This is the oldest system used by oncologists, and is used only for patients diagnosed with a variety of pleural mesothelioma. In Phase 3, the cancer has spread from the abdomen to the pleural lining. The entire lymphatic system may also be involved this time.

TMN System
TNM mean tumor, lymph nodes and metastases. This is a newer method that is commonly used for staging of malignant pleural mesothelioma, although it is also used for peritoneal mesothelioma as well.

Under the third phase of this system, the cancer has spread from the pleural lining the heart, ribs, esophagus and other organs. At this point, the lymphatic system was definitely affected.

Brigham System
This is the new testing system, which was specially developed for use in cases of mesothelioma. Under Phase 3 of the Brigham System, the cancer is inoperable due to its spread into other areas. Tumors may be located in areas of difficult access, or may be widespread. Moreover, the cancer has affected the lymphatic system.

Prognosis
So far the disease has reached stage 3, the prognosis for mesothelioma is grim. Even if the primary tumor can be removed, cancer cells have spread more likely than other areas, and a remission or cure mesothelioma mesothelioma is not likely. At this point, palliative treatments that can reduce pain and make patients more comfortable during his last days are usually the only viable options.

In order to assess the extent and nature of any type of cancer, inclucing mesothelioma cancer, oncologists use a heading or “test” the system. This is just one of the criteria used to classify malignant tumors. Additional features include the location of the tumor and identification of cell types of mesothelioma.

Staging helps doctors mesothelioma in determining how far the cancer has progressed asbestos and mesothelioma treatment that would be appropriate.

Although there are three different staging systems currently in use, all three are based in four main steps:

• The tumor in stage 1 mesothelioma is confined to one organ or region, and is relatively small.
• The tumor in Stage 2 mesothelioma has grown in size and spread to another tissue.
• The tumor in stage 3 mesothelioma has spread to adjacent areas.
• The tumor in Stage 4 mesothelioma has spread to distant areas of the body, or “metastasis”.
In Stage 4, the cancer has spread throughout the body and mesothelioma life expectancy is not long.

Butchart System
This is the oldest system used by oncologists, and is used only for patients diagnosed with a variety of pleural mesothelioma. In Phase 4 under the Butchart System, the cancer has spread through the bloodstream and can be found in all parts of the body distant from the point of origin of the tumor.

TMN System
TNM mean tumor, lymph nodes and metastases. This is a newer method that is commonly used for staging of malignant pleural mesothelioma, although it is also used for peritoneal mesothelioma as well.

Under this system, the cancer has spread beyond the original site and neck, as well as the lymphatic system.

Brigham System
This is the new testing system, which was specially developed for use in cases of mesothelioma.

In Phase 4 of the Brigham System, the cancer is inoperable. Tumors are either too large to remove surgically or have penetrated deep into vital organs. The cancer has metastasized to the point that malignant cells can be found throughout the patient’s body, so that even if some of them can be removed, the cancer will almost certainly be repeated elsewhere.

Prognosis
In Stage 4, the prognosis of mesothelioma is identified as terminal, and the patient has less than a year to live in most cases. At present, doctors focus on issues of quality of life, offering palliative care that can at least reduce patient discomfort and pain.

If you believe you may have mesothelioma, a qualified medical professional will use a variety of tests and diagnostic methods to confirm the presence of the disease.

Review the medical history and examination
The first step for physicians in the evaluation of mesothelioma has an asbestos related disease is to obtain a complete medical history to determine the level and severity of risk factors and symptoms of mesothelioma mesothelioma. This interview will look to consider, among other things, where there was exposure to asbestos, exposure duration and amount of asbestos they were exposed.

In addition, he / she will conduct a medical examination for signs and symptoms of various types of mesothelioma. For example, if the pleural mesothelioma is suspected, the doctor will look for the fluid in the thorax, peritoneal mesothelioma often shows fluid in the abdomen and pericardial mesothelioma presents with fluid in the heart area.

Tests of diagnostic
Chest X-rays are used to identify lung abnormalities, including abnormal thickening, mineral deposits and fluid in the chest area. If these conditions are present, then it may be evidence that has been developing mesothelioma.

diagnostic imaging tests such as x-rays, CT scans and MRI are useful in determining more information about cancer, including how it progressed. Each method provides another piece of information with your doctor to help make an accurate diagnosis. CT is capable of providing images of the same site from many different angles. MRI technology uses magnetic fields instead of x-ray to provide complementary views.

Testing samples of body fluids and tissues
The accumulation of fluid in the chest, abdomen or heart region is present, your doctor may want to sample. To accomplish this, he / she will use a long needle to obtain fluid from the target area. The fluid is sent to the laboratory for analysis.

A bronchoscopy procedure can be recommended for patients with suspected pleural mesothelioma. For this test a doctor, a soft tube illuminates the trachea and bronchi to determine whether any bodies are present in the airways. If necessary, the technician take my sample of tissue that appears abnormal for more tests.

If the lymph node involvement is suspected that is common with lung cancer from asbestos, patients may also suffer a mediastinoscopy. This procedure is similar to a bronchoscopy in a soft tube that enters the body under the breast bone and illuminates the breast area. Thus, the surgeon can examine the lymph nodes of anomalies, check to see how far the disease may have progressed and where necessary, to help diagnose lung cancer from mesothelioma.

Diagnosing mesothelioma is never easy. Fluid build yourself in the chest, belly or the heart of the regions is not sufficient to confirm a diagnosis. Tissue samples obtained from biopsy procedures are also difficult to discern because the cells of mesothelioma cancer often resemble other types of cancer. For this reason, specialized laboratory procedures are often used to identify certain chemicals that are known mesothelioma with laboratory equipment and high power is used to examine the smallest details of cancer cells to confirm that mesothelioma is present.

Mesothelioma is difficult to diagnose because early signs and symptoms of the disease may be subtle at best. The symptoms are too often ignored or rejected by people who are inclined to attribute them to common diseases every day. Sometimes, patients live with symptoms for up to six months before being diagnosed, but symptoms are usually present in two or three months before the diagnosis of mesothelioma.

About 60% of patients diagnosed with pleural mesothelioma experience backache or pain in the chest side and there are frequent reports of shortness of breath. Fewer people may have difficulty swallowing or have a persistent cough, fever, weight loss or fatigue. Symptoms also consider are muscle weakness, sensory loss, coughing up blood, swelling of the face and arm and hoarseness.

Peritoneal mesothelioma originates in the abdomen and as a result, symptoms typically include abdominal pain, weight loss, nausea and vomiting. In the event that there is a hernia present, fluid build up can also occur in the abdomen.

Any person previously exposed to asbestos see any of these symptoms should seek medical attention from physicians who specialize in mesothelioma treatment of mesothelioma as Dr. David Sugarbaker.

What are the main causes of mesothelioma?
Mesothelioma is predominantly caused by exposure to asbestos. Asbestos fibers that are inhaled through the mouth and nose may eventually become embedded in the lining of the lungs, causing damage and resulting in mesothelioma lung cancer or asbestosis (scar tissue in the lungs). They also found that ingestion of asbestos fibers can contribute to a form of mesothelioma originating in the abdomen called peritoneal mesothelioma.

Mesothelioma cancer usually results from occupational exposure, but there are cases of environmental exposure to asbestos that can cause disease mesothelioma. Often the exposure to second hand of a family member of a workers’ asbestos-soiled clothing to work may result in the family member with a diagnosis of mesothelioma.

asbestos insulation workers seem to have the highest rate of death. One study reports that almost six percent of asbestos workers are victims of mesothelioma or experience symptoms of mesothelioma and asbestos insulation workers are more than 300 times more likely to die from mesothelioma than the general public.

Nanotechnology is the emerging scientific study related to the use of small, thin, carbon-based materials known as nanotubes. A multitude of products nanotubes are becoming more widely used. These products range from technologically advanced items utilized by NASA to everyday objects used at home. Nanotubes are increasingly popular because of its lightness and supreme force, said to be stronger than steel.

As the variety of uses for the increase of nanotubes, researchers continue to make studies and tests related to the consequences of using nanotubes. Current research says that exposure to thin and long version of carbon nanotubes based may lead to the development of pleural mesothelioma, a deadly form of cancer that affects the lining of the lungs and has no known cure. Scientists say there is no reason for immediate concern, but that further tests related to nanotube exposure and the onset of mesothelioma is crucial. As with exposure to asbestos, the nanotubes are only potentially dangerous if the tiny fibers are inhaled, putting manufacturers, laboratory researchers, suppliers and other professionals who can handle more exposed nanotubes.

What types of products containing nanotubes?
Carbon nanotubes are used based on a wide variety of items including sports apparel, automotive parts, electronics, advanced tools and medical items, such as parts of the space shuttle, currently under development by NASA. For your reference we have prepared a full list of products that may contain nanotubes.

What are the risks associated with exposure of nanotubes?
Currently, scientists and researchers to assure the public that there is no reason for immediate concerns related to the exposure of nanotubes. The risk of developing pleural mesothelioma is higher if the tiny fibers of carbon-based nanotubes are inhaled and the risk associated with the inhalation of asbestos. However, those dealing with manufacturing of nanotubes in testing phases and are at risk if you do not use breathing apparatus and other necessary equipment.